"We are strategically building the team to bolster our capabilities as we scale up our laboratory operations to address the largely untapped $6billion+ U.S. addressable market for CNSide cerebrospinal ...

Europe has significantly scaled back its ambitious ESG reporting rules, dropping climate transition requirements and reducing compliance for over 80% of companies.

Q3 2025 Management View Andrew McLean, CEO, highlighted "a strong demonstration of our strategy and its ability to drive value for all stakeholders," citing "gross margin expansion, stronger customer ...